Table 4.
Heat Map of IC50 Values (μM) for New-Generation Peptides against a Broader Panel of HIV Env-Pseudotyped Strains
| R5a | R5/X4a | X4a | ||||||
|---|---|---|---|---|---|---|---|---|
| Peptide | YU2b | BaL26b | JRFLb | JRCSFb | SF162b | 89.6b | HxB2b | NL4–3b |
| 2Cc | 30 | 65 | NDd | NAd | NAd | NAd | 54 | 53 |
| 16–2 | 5 | NDd | NDd | NDd | NDd | NAd | 167 | 44 |
| 18–2 | 1.9 | 27 | NDd | NDd | NDd | 132 | 72 | 12 |
| 20–2 | 0.42 | 14 | 56 | NAd | NAd | 13 | >50 | 8 |
| 20–5 | 0.72 | 9.5 | 75 | NAd | NAd | 7 | >100 | 6 |
| 30–2 | 0.96 | 6 | 8 | 47 | 24 | 0.57 | 21 | 4 |
| 40–2 | 0.26 | 21 | 35 | 91 | 69 | 27 | 40 | 17 |
Virus tropism. R5, R5/X4, and X4 are CCR5-, dual-, and CXCR4-tropic strains, respectively. Neutralization assays were performed as described previously.9
HIV strain.
Reference 5.
IC50 (μM) key: red, <1; orange, <15; yellow, ≤40; green, ≤100; white, >100 or ND, not determined; gray, NA, not active at ≤500 μM.